The Irish Pharmaceutical Healthcare Association (IPHA) has said that patients in Ireland could get access to new medicines a year earlier, if there were reforms here.
The new Programme for Government said the coalition is committed to ensuring that patients have access to news medicines as quickly as possible.
The IPHA has said it is clear that the system for covering new medicines needs to be funded, governed and designed to operate within the legal 180-days timeline set by the Oireachtas.
Meanwhile, a new four-year Framework Agreement on the pricing and supply of medicines between the State and IPHA is due to be negotiated this year.
https://www.rte.ie/news/2025/0226/1498941-ipha-medicines/
Interesting discussion on the “human cost” of delayed approval….
“System not very transparent”
“Strategically a commercial process”
“Difficult conversations on a daily basis”
Lynch Syndrome Ireland 